These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14516487)

  • 1. Tentative identification of novel oxycodone metabolites in human urine.
    Moore KA; Ramcharitar V; Levine B; Fowler D
    J Anal Toxicol; 2003 Sep; 27(6):346-52. PubMed ID: 14516487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases.
    Pantano F; Brauneis S; Forneris A; Pacifici R; Marinelli E; Kyriakou C; Pichini S; Busardò FP
    Clin Chem Lab Med; 2017 Aug; 55(9):1324-1331. PubMed ID: 28080998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications.
    Fang WB; Lofwall MR; Walsh SL; Moody DE
    J Anal Toxicol; 2013; 37(6):337-44. PubMed ID: 23743505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives.
    Cone EJ; Zichterman A; Heltsley R; Black DL; Cawthon B; Robert T; Moser F; Caplan YH
    Forensic Sci Int; 2010 May; 198(1-3):58-61. PubMed ID: 20036472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine drug testing for oxycodone and its metabolites as a tool for drug-drug interactions?
    Mikus G
    J Anal Toxicol; 2015; 39(1):81-2. PubMed ID: 25288721
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to urine drug testing for oxycodone and its metabolites as a tool for drug-drug interactions.
    Elder NM; Atayee RS; Best BM; Ma JD
    J Anal Toxicol; 2015; 39(1):80. PubMed ID: 25288719
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations of urinary oxycodone and metabolite distributions in pain patients.
    Elder NM; Atayee RS; Best BM; Ma JD
    J Anal Toxicol; 2014 Apr; 38(3):129-34. PubMed ID: 24523296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.
    Heltsley R; Zichterman A; Black DL; Cawthon B; Robert T; Moser F; Caplan YH; Cone EJ
    J Anal Toxicol; 2010; 34(1):32-8. PubMed ID: 20109300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches.
    Protti M; Catapano MC; Samolsky Dekel BG; Rudge J; Gerra G; Somaini L; Mandrioli R; Mercolini L
    J Pharm Biomed Anal; 2018 Apr; 152():204-214. PubMed ID: 29414014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease.
    Samolsky Dekel BG; Donati G; Vasarri A; Croci Chiocchini AL; Gori A; Cavallari G; Di Nino G; Mercolini L; Protti M; Mandrioli R; Melotti RM; La Manna G
    Pain Pract; 2017 Jun; 17(5):604-615. PubMed ID: 27589376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.
    Smith ML; Hughes RO; Levine B; Dickerson S; Darwin WD; Cone EJ
    J Anal Toxicol; 1995; 19(1):18-26. PubMed ID: 7536861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncertainty in assessing impact of drug-drug interactions on oxycodone metabolite patterns.
    DePriest AZ; Puet BL; Heltsley R; Robert T; Black DL
    J Anal Toxicol; 2014 Sep; 38(7):462. PubMed ID: 24986837
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration.
    Cone EJ; Heltsley R; Black DL; Mitchell JM; Lodico CP; Flegel RR
    J Anal Toxicol; 2013 Jun; 37(5):255-64. PubMed ID: 23609023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory.
    Haller CA; Stone J; Burke V; Branch J; Chen K; Gross S
    J Anal Toxicol; 2006 Mar; 30(2):106-11. PubMed ID: 16620541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography-tandem mass spectrometry.
    Gaudette F; Sirhan-Daneau A; St-Onge M; Turgeon J; Michaud V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():174-180. PubMed ID: 26655109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authors' reply.
    Elder NM; Atayee RS; Best BM; Ma JD
    J Anal Toxicol; 2014 Sep; 38(7):463. PubMed ID: 24986838
    [No Abstract]   [Full Text] [Related]  

  • 17. Measurements of plasma oxycodone, noroxycodone and oxymorphone levels in a patient with bilateral nephrectomy who is undergoing haemodialysis.
    Lee MA; Leng ME; Cooper RM
    Palliat Med; 2005 Apr; 19(3):259-60. PubMed ID: 15920941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
    Boström E; Jansson B; Hammarlund-Udenaes M; Simonsson US
    Rapid Commun Mass Spectrom; 2004; 18(21):2565-76. PubMed ID: 15468158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry.
    Neuvonen M; Neuvonen PJ
    Ther Drug Monit; 2008 Jun; 30(3):333-40. PubMed ID: 18520605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the usefulness of an oxycodone immunoassay in combination with a traditional opiate immunoassay for the screening of opiates in urine.
    Gingras M; Laberge MH; Lefebvre M
    J Anal Toxicol; 2010 Mar; 34(2):78-83. PubMed ID: 20223099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.